Operating Lease, Right-of-Use Asset of AMICUS THERAPEUTICS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AMICUS THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • AMICUS THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $21,549,000, a 6.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AMICUS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $21,549,000 -$1,595,000 -6.9% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $21,988,000 -$623,000 -2.8% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $22,138,000 -$865,000 -3.8% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $22,278,000 -$4,034,000 -15% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $23,144,000 -$6,367,000 -22% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $22,611,000 -$5,431,000 -19% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $23,003,000 -$5,480,000 -19% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $26,312,000 -$3,222,000 -11% 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $29,511,000 -$360,000 -1.2% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $28,042,000 -$2,405,000 -7.9% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $28,483,000 +$974,000 +3.5% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $29,534,000 +$8,948,000 +43% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $29,871,000 +$8,601,000 +40% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $30,447,000 +$8,419,000 +38% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $27,509,000 +$5,146,000 +23% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $20,586,000 -$2,710,000 -12% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $21,270,000 -$2,127,000 -9.1% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $22,028,000 -$1,921,000 -8% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $22,363,000 -$10,138,000 -31% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $23,296,000 -$10,019,000 -30% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $23,397,000 -$12,417,000 -35% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $23,949,000 -$11,103,000 -32% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $32,501,000 -$3,707,000 -10% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $33,315,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $35,814,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $35,052,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $36,208,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.